Non-Alzheimer's and Atypical Dementia

• Focuses on non-Atypical Dementia 
• Multidisciplinary approach to diagnosis and management
• Allows development of management and care plan strategies
• Practical approach including case studies
• Written by a world-renowned editorial team

Notes on contributors, vi

1 Introduction, 1
Michael D. Geschwind and Caroline Racine Belkoura

2 The multidisciplinary evaluation of the atypical dementia patient, 6
Michael D. Geschwind and Caroline Racine Belkoura

3 Atypical Alzheimer’s disease, 17
Sharon J. Sha and Gil D. Rabinovici

4 Vascular cognitive impairment: Diagnosis and treatment, 30
Helena C. Chui and Liliana Ramirez-Gomez

5 Frontotemporal dementia, 49
David C. Perry and Howard J. Rosen

6 Lewy body dementias (DLB/PDD), 64
Carol F. Lippa and Katherine L. Possin

7 Corticobasal degeneration and progressive supranuclear palsy, 77
Suzee E. Lee and Bruce L. Miller

8 Repeat expansion diseases and dementia, 90
Praveen Dayalu, Roger L. Albin and Henry Paulson

9 Prion diseases and rapidly progressive dementias, 103
Leonel T. Takada and Michael D. Geschwind

10 Autoimmune dementias, 123
Andrew McKeon and Sean J. Pittock

11 Toxic and metabolic dementias, 134
Michelle Mattingly, Katie Osborn and Leon Prockop

12 Leukoencephalopathies/leukodystrophies, 150
Gregory M. Pastores and Swati A. Sathe

13 Infectious causes of dementia, 170
Cheryl A. Jay, Emily L. Ho and John Halperin

14 Rheumatologic and other autoimmune dementias, 186
Laura J. Julian and Christopher M. Filley

15 Comprehensive management of the patient with an atypical dementia, 202
Jennifer Merrilees, Cynthia Barton, Amy Kuo and Robin Ketelle

Index, 215

Michael Geschwind, MD PhD
Dr. Geschwind received his MD and PhD in neuroscience through the National Institutes of Health-sponsored Medical Scientist Training Program at the Albert Einstein College of Medicine in New York. He completed his internship in internal medicine at the University of California, Los Angeles Medical Center, his neurology residency at the Johns Hopkins University School of Medicine in Baltimore and his fellowship in behavioral neurology at the UCSF Memory and Aging Center (MAC). He joined the Memory and Aging Center faculty in 2003 and is an Associate Professor of Neurology.

Dr. Geschwind evaluates patients in the MAC new patient clinic and participates in the management and care for these patients in the MAC continuity clinic. He is active in the training of medical students and residents at UCSF. Dr. Geschwind teaches a national course and lectures, both nationally and internationally, on the assessment of rapidly progressive dementias, including human prion diseases.

Dr. Geschwind's primary research interest is the assessment and treatment of rapidly progressive dementias, including prion diseases such as Creutzfeldt-Jakob disease (CJD). Dr. Geschwind helped establish an inpatient hospital program for the assessment of rapidly progressive dementias at UCSF, one of the first of its kind in the country. He ran the first ever US treatment study for CJD. He also has an active research interest in cognitive dysfunction in movement disorders, such as Huntington's disease, corticobasal degeneration (CBD), progressive supranuclear palsy (PSP) and other Parkinsonian dementias.

Caroline Racine Belkoura, PhD
Caroline Racine Belkoura received her BA in Psychology from Boston University, where she completed an honors thesis exploring visual-perceptual deficits in patients with stroke and traumatic brain injury. From 1997-1999 she worked as a research assistant with Dr. Dan Schacter at Harvard Univ